LabCompass

Lukman O. Afolabi

Immunology and Microbiology · Indiana University

OpenAlex ORCID
Immune Cell Function and InteractionImmune cells in cancerCancer, Lipids, and MetabolismCancer, Hypoxia, and MetabolismCAR-T cell therapy research

Publications

36

Citations

1,166

Est. group size

—

Recurring co-author estimate

Active years

15

Publishing since 2012

Research summary
AI-generated

Lukman O. Afolabi studies cancer immunology, focusing on how the immune system can be engineered and boosted to attack tumors. Much of the work centers on cellular therapies such as CAR-T cells (immune cells modified to target cancer) and natural killer (NK) cells, along with strategies to overcome the ways tumors suppress immune responses. Additional projects explore natural compounds against cancer and bibliometric analyses of medical research fields.

CAR-T and NK cell cancer immunotherapyTumor immune suppression and microenvironmentCancer metabolism and cell signalingNatural compounds and drug effects on tumorsBibliometric and literature analyses

Publication activity rose to a peak around 2020-2022 and has been somewhat lower and variable since, averaging about 3 papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.2/year recently
2017: 1 publication172018: 1 publication182019: 2 publications192020: 5 publications202021: 7 publications7212022: 6 publications222023: 3 publications232024: 1 publication242025: 4 publications252026: 2 publications26
Recent publications
Publishes in
  • Frontiers in Immunology×3
  • Cancer Control×2
  • Immunology×2
  • The Journal of Immunology×2
  • Frontiers in Oncology×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile